Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072682 · ClinicalTrials.gov registry record · NA
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
A NA study, sponsored by SeaStar Medical.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01072682 is a NA study that has completed, run by SeaStar Medical. The registered enrollment target is 35 participants.
The verdict
NCT01072682, a NA study, has completed, sponsored by SeaStar Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute renal failure (ARF).
Interventions
- DEVICE Selective cytopheretic device (SCD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01072682
The ClinicalTrials.gov registry entry for NCT01072682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SeaStar Medical, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Selective cytopheretic device (SCD) is the first listed.
NCT01072682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01072682 about?
NCT01072682 is a clinical study titled "Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure". The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute renal failure (ARF).
What is the current status of trial NCT01072682?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2010-02. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01072682?
The interventions under investigation include: Selective cytopheretic device (SCD) (DEVICE).
Who is sponsoring clinical trial NCT01072682?
This trial is sponsored by SeaStar Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.